Skip to content
TrialScanner

NCT02480374

Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian Cancer

Phase 1CompletedIMNNLead

Registry record

Lead sponsor
Imunon
Conditions
Epithelial Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer
Primary completion
May 2017Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02480374 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02480374: Study of Safety & Biological... | TrialScanner